During the past decade, Otsuka Pharmaceutical Co., Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Otsuka Pharmaceutical Co., Ltd." are "Autism" (1 trials), "Cerebral Infarction" (1 trials), "Dry Eye Syndromes" (1 trials), "Edema" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Otsuka Pharmaceutical Co., Ltd." in a lesser frequency.

Most popular intervention types in "Otsuka Pharmaceutical Co., Ltd." are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Rebamipide" (2 trials), "0.5% OPC-12759" (1 trials), "1% OPC-12759" (1 trials), "2% OPC-12759" (1 trials) and "Aripiprazole oral product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Otsuka Pharmaceutical Co., Ltd." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Otsuka Pharmaceutical Co., Ltd.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Otsuka Pharmaceutical Co., Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Otsuka Pharmaceutical Co., Ltd., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".